News Archives
Compilation of news articles and media releases featuring faculty, staff and events at Winship Cancer Institute of Emory University.
Compilation of news articles and media releases featuring faculty, staff and events at Winship Cancer Institute of Emory University.
The New England Journal of Medicine highlights the FDA's approval of a breakthrough treatment for B-cell acute lymphoblastic leukemia, made possible by research conducted at Winship.
Researchers from Winship Cancer Institute of Emory University present emerging pre-clinical, epidemiological and clinical data in blood cancers and blood disorders at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, Dec. 7-10, 2024.
Winship held its annual scientific symposium at the Emory Conference Center Hotel on Nov. 11, exploring advances in cancer research and care through the theme “Synergy in Science: Fostering Collaborative Cancer Research in Georgia.”
Researchers from Winship and partner institutions aim to better understand and reduce health disparities in diffuse large B-cell lymphoma through a collaborative initiative supported by a $5 million grant from The Leukemia & Lymphoma Society.
The 2024 Winship Gala, held at the St. Regis Atlanta on Saturday, Nov. 9, raised more than $1.8 million to support clinical trials and research projects at Winship Cancer Institute of Emory University.
Ten research teams co-led by investigators from Winship and the American Cancer Society have been awarded a total of $1 million in pilot grant funding to accelerate advances in cancer prevention, diagnosis, discovery, treatment and survivorship.
Winship researchers have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity.
A new partnership between Winship and the Center for New Medicines at Emory University School of Medicine will expedite the drug discovery pipeline that translates fundamental biological discoveries into next generations of lifesaving treatments for patients with cancer.
Winship researcher and physician Reshma Jagsi, MD, DPhil, has been elected to the National Academy of Medicine, one of the highest honors in health and medicine, for pioneering research in disparities in cancer outcomes and within the medical profession.
Results from a phase 3 clinical trial, co-led by Winship researchers and published in The New England Journal of Medicine, highlights a new standard of care for advanced stage classic Hodgkin lymphoma and may help increase access to the new therapy for teens and young adults.
The International Myeloma Society has awarded the 2024 Bart Barlogie Clinical Investigator Award to Sagar Lonial, MD, FACP, Winship's chief medical officer, at the society's annual meeting in Rio de Janeiro, Brazil, Sept. 25-28.
Twenty-six nurses graduated on Sept. 25 from Winship’s Oncology Nurse Residency Program, designed to support nurses as they transition into the specialized field of oncology.
Research led by Winship investigators and published in JCO Oncology Practice finds that continuity of Medicaid coverage increases the survival rates of children and adolescents with cancer.
The 2024 Winship 5K Run/Walk on Sept. 28 had more than 3,500 participants and raised more than $1 million in support of cancer research and care at Winship Cancer Institute of Emory University.
Advanced practice providers gathered on the Emory University campus Sept. 13-14 to learn the latest, evidence-based strategies to optimize care and outcomes for patients with cancer.
Daniel M. Halperin, MD, a renowned clinical trialist and board-certified medical oncologist specializing in neuroendocrine tumors (NETs), joins Winship Cancer Institute of Emory University as vice chair for clinical affairs and associate professor in Emory University School of Medicine's Department of Hematology and Medical Oncology on Sept. 1.
Ravi B. Parikh, MD, MPP, FACP, an acclaimed physician-scientist and expert in health care artificial intelligence and machine learning, joins Winship as the new medical director of the Winship Data and Technology Applications Shared Resource on Sept. 1.
Landmark CoMMpass study offers a comprehensive understanding of the multiple myeloma’s progression from a treatable condition to a high-risk state by providing unprecedented insights into the genetic diversity and subtypes of the disease.
Four Winship trainees are recipients of this year's Nell W. and William S. Elkin Fellowships and Chester P. Rochfort Scholarships.
Winship researcher, Reshma Jagsi, MD, DPhil, Lawrence Davis professor and chair of radiation oncology at Emory University School of Medicine, has been awarded the 2024 Marion Spencer Fay Award.
Twelve high school students conducted laboratory experiments and learned about clinical and basic science cancer research as part of the 2024 Winship Summer Scholars Research Program.
Twenty-four nurses recently graduated from Winship’s Oncology Nurse Residency Program, designed to support nurses as they transition into the specialized field of oncology.
U.S. News and World Report ranks Winship Cancer Institute of Emory University at Emory University Hospital as among the most “high performing” 10% of hospitals providing cancer care nationwide —and as number one in Georgia and metro Atlanta.
Winship led study reveals a new AI-based computational pathology tool designed to better manage treatment for patients with ductal carcinoma in situ (DCIS), a form of pre-invasive breast cancer.
Winship physicians are among the 495 Emory Healthcare doctors recognized in Atlanta magazine’s annual roster of the city's best doctors.
Winship researcher Deborah Watkins Bruner, RN, PhD, FAAN, played a key role in the update of ASCO's guideline on the Management of Fatigue in Adult Survivors of Cancer, providing clinicians with evidence-based recommendations to manage cancer-related fatigue effectively and enhance the overall well-being of cancer survivors.
Findings from the LAURA Phase III trial—presented at the ASCO Annual Meeting by Winship Executive Director Suresh Ramalingam, MD, and simultaneously published in The New England Journal of Medicine—show osimertinib significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new hope for those with advanced EGFR-mutated non-small cell lung cancer.
Winship physicians and scientists will present new cancer research findings and offer expert perspectives at the world's largest clinical cancer research meeting, the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
A Winship study suggests immunotherapy combined with second-time radiation therapy may improve the chances of halting cancer progression compared to current standard treatments, while also being well tolerated.
In the year since Winship at Emory Midtown opened its doors, the new care center has already made tremendous strides toward fulfilling the challenge from the Woodruff Foundation to "build something never seen or imagined."
Clinicians and researchers from Winship Cancer Institute of Emory University presented their latest findings at the 49th Annual Congress of the Oncology Nursing Society (ONS) in Washington, D.C., April 24-28, 2024.
The 2024 Friends of Winship Fashion a Cure Fashion Show on April 30 raised $370,000 to support research at Winship Cancer Institute of Emory University in cancers that affect women and their care.
Winship and the University of Georgia hosted nearly 100 researchers on the Emory campus for the 2024 UGA-Winship Cancer Research Summit on April 22.
Emory College junior Satvik Elayavalli working as an assistant researcher with Winship scientists was recently named one of two Emory undergraduates to be among the recipients nationwide of the prestigious 2024 Goldwater Scholarship.
Winship researchers led by Yong Teng, PhD, conducted a noteworthy study that could impact future treatment of squamous cell head and neck cancer, particularly in the context of radiotherapy.
A new Winship-led study published recently by JAMA Network Open examines the prevalence of mental health challenges faced by parents caring for children diagnosed with cancer.
Winship researchers will present key lectures and share their latest discoveries at the 115th annual meeting of the American Association for Cancer Research in San Diego, April 5-10, 2024.
Forty health professionals, clinicians and journalists from France and Belgium attended a March 8 presentation and tour of Winship Cancer Institute at Emory Midtown.
Winship medical oncologist Mehmet Asim Bilen, MD, is the inaugural Champions and Friends of Dunwoody Country Club Professor in Prostate Cancer.
Lauren McCullough, PhD, MSPH, is part of an international team that was awarded a $25 million grant to help address cancer disparities in populations of African ancestry.
Nine teams of Winship investigators will receive a total of $450,000 for new cancer research projects.
Twenty-one graduates comprised the first cohort of Winship’s Oncology Nurse Residency Program, which launched in spring 2023.
Winship researcher Kelly Goldsmith, MD, has been named the inaugural Curing Kids Cancer Professor of Pediatric Oncology.
Gregory B. Lesinski, PhD, MPH, and Stephen Hajduk, PhD, have received a one-year, $50,000 Winship-UGA Collaborative Pilot Grant to advance their innovative, inter-institutional project.
As Winship's assistant director for community outreach and engagement, Jessica Wells, PhD, FAAN, will help facilitate and implement key priorities to reduce the burden of cancer across Georgia.
The 2024 Georgia Cancer Summit assembled community organizations, academic institutions, governmental entities and industry partners to address the shared goal of reducing the burden of cancer in the state.
Jennifer Morthland, CFRE, has been named Winship's assistant vice president of advancement, leading advancement efforts, fundraising strategy and development team in support of Winship's mission.
Daniela Jordan Casbourne, MSN, AGACNP-BC, FNP-BC, AOCNP, has been named advanced practice provider (APP) chief for Winship Cancer Institute of Emory University.
Cancer drug shortages happen, but Winship's pharmacists track and anticipate them to avoid any interruptions in our patients' treatment.
Winship researcher Reshma Jagsi, MD, DPhil, has been awarded the 2023 American Association for Women in Radiology Marie Sklodowska-Curie Award.
Nearly 200 people gathered on Dec. 6 for the Winship Scientific Symposium which featured presentations and interactive sessions including a keynote talk by Carl June, MD, and an evening poster reception.
Winship clinicians and staff who work at the Emory Proton Therapy Center gathered there on December 1 to celebrate the center’s fifth anniversary.
Winship researcher Reshma Jagsi, MD, DPhil, recently concluded a study that may offer an alternative to the current conventional approach to treating postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer.
Researchers from Winship Cancer Institute of Emory University will share scientific advances and clinical updates in blood diseases at the global 65th Annual Meeting of the American Society of Hematology in San Diego, Dec. 9-12, 2023.
Physicians and researchers from Winship Cancer Institute of Emory University will present new and late-breaking data at the 46th San Antonio Breast Cancer Symposium in San Antonio, Dec. 5-9, 2023.
The new Georgia Blood Cancer Trials Network will make innovative, investigational therapies and treatments more accessible to patients with blood cancer in Georgia's rural and high-poverty areas.
The new Emory AI.Health, led by Winship member Anant Madabhushi, PhD, will foster the development of accessible, cost-effective and equitable AI tools including methods for improving cancer diagnostics and treatment.
Winship researchers will chair sessions, receive awards and present groundbreaking work in immune-based cancer treatments and techniques at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego, Nov. 1-5, 2023.
On Oct. 7, bright blue skies and crisp cool autumn weather provided a cheery backdrop for more than 3,000 Winship 5K participants who with the help of sponsors and donors raised more than $1 million for cancer research at Winship.
The $100,000 Emory Max Cooper Prize in Immunology is an annual award honoring Winship member Dr. Max D. Cooper, whose historic discoveries have forever changed our understanding of the adaptive immune system.
Winship radiation oncologists and researchers will lead 34 presentations, posters and moderated sessions at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego, Oct. 1-4, 2023.
Winship head and neck surgeon Mihir R. Patel, MD, shares his inspiration behind his participation in the annual Winship 5K run/walk.
Winship researcher Ilana Graetz, PhD, has been named the new leader of Winship’s Cancer Prevention and Control (CPC) Research Program, effective September 1.
A study co-led by Winship researcher Reshma Jagsi, MD, DPhil, found that representation of women physicians in movies was much lower than the growing proportion of women in medicine.
Winship Executive Director Suresh Ramalingam, MD, was awarded the Paul A. Bunn, Jr. Scientific Award Sep. 9 at the 2023 IASLC World Conference on Lung Cancer.
Promising results from the Phase 3 LUNAR clinical trial for non-small cell lung cancer led by Winship thoracic oncologist Ticiana Leal, MD, were published in The Lancet Oncology.
Winship hematologist-oncologist Ajay K. Nooka, MD, MPH, has been named Winship’s associate director for clinical research, effective Sept. 1.
U.S. Department of Health and Human Services has selected Winship researchers among the inaugural recipients of funding to support transformative breakthroughs in health research including cancer and immunology.
This year's UGA-Winship Cancer Research Summit highlighted the research strengths of the two institutions and explored opportunities to collaborate on cancer prevention, diagnosis and treatment efforts.
Six investigators will receive $300,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University.
Researchers from Winship and Case Western Reserve University have developed a method using artificial intelligence and machine learning to determine whether treatment with CDK4/6 inhibitors will be effective for patients with metastatic breast cancer.
U.S. News and World Report’s highly anticipated list, released today, ranks cancer care provided by Winship Cancer Institute of Emory University among the best in the United States.
A new center at Winship Cancer Institute of Emory University will focus research efforts on eliminating cancer disparities in Georgia and nationwide.
The Winship Summer Scholars Research Program wrapped up on July 14 with a final symposium in which each student presented a research talk and scientific poster.
Six Winship trainees are recipients of this year's Nell W. and William S. Elkin Fellowships and Chester P. Rochfort Scholarships.
Winship physicians are among the over 400 Emory Healthcare doctors recognized in Atlanta magazine’s annual roster of the city's best doctors.
Gregory B. Lesinski, PhD, MPH, has been named the John Kauffman Family Professor at Winship Cancer Institute of Emory University.
Winship surgical oncologist Maria C. Russell, MD, has been named chief quality officer for Winship Cancer Institute of Emory University.
Winship researchers demonstrate for the first time that applying the same radiation therapy dose to the heart’s substructures as a uniform dose to the whole heart in children with cancer puts them at higher risk for future heart complications.
Winship has received renewal of the prestigious Comprehensive Cancer Center designation from the National Cancer Institute (NCI), ensuring its continuing place in the top tier of cancer centers in the United States.
A new study led by Winship researcher Reshma Jagsi, MD, DPhil, finds that women and underrepresented groups experience higher rates of workplace mistreatment in academic medicine.
A phase 3 trial evaluated at Winship shows promising results with Tumor Treating Fields therapy in combination with standard of care for patients with metastatic non-small cell lung cancer.
An innovative study led by Winship investigators has uncovered a simplified, economical manufacturing process for generating more potent and metabolically fit human T-cell therapies to treat solid tumors.
Winship researcher David M. Schuster, MD, was the coordinating investigator for a phase 3 clinical trial of POSLUMA, the first radiohybrid drug for PET imaging of prostate-specific membrane antigen-positive lesions in men with prostate cancer.
Winship clinicians and scientists will lead sessions and share their latest discoveries at the annual meeting of the American Society of Clinical Oncology in Chicago, June 2-6, 2023.
Supported by a unique endowment created by Atlantan Bernard "Berny" Gray, the Winship Catalyst Fund will enable Winship researchers to bring promising drugs and treatment strategies from discovery to clinical use.
Four investigators from Winship Cancer Institute of Emory University have been awarded pilot grants from the Donaldson Charitable Trust Research Synergy Fund.
The new Winship Cancer Institute at Emory Midtown will open for patients on May 9. A ribbon-cutting event on May 2 celebrating the opening of the building featured remarks from Atlanta Mayor Andre Dickens and several Emory dignitaries.
More than 700 communications and development professionals from cancer centers across the country gathered in Atlanta for the NACCDO-PAMN annual conference, April 24-27, 2023.
The 2023 Friends of Winship Fashion a Cure Fashion Show on April 18 raised more than $340,000 to support research conducted at Winship Cancer Institute of Emory University in cancers that affect women.
Winship faculty and trainees will lead sessions and share their latest discoveries at the 2023 American Association for Cancer Research Annual Meeting taking place in Orlando, Florida, April 14-19.
A Winship-led phase 2 clinical trial shows a combination of two drugs was well tolerated and benefitted 91% of participating patients with recurrent/metastatic head and neck squamous cell carcinoma.
In a significant step for the treatment of neuroblastoma, an international group of researchers led by Winship researcher Kelly Goldsmith, MD, has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma..
Timothy L. Lash, DSc, MPH, has been named Winship associate director for population sciences to direct the integration and strategic growth of population science-based research throughout Winship and its research programs.
Winship Cancer Institute and Emory University School of Medicine mourn the loss of an esteemed cancer researcher and beloved member of the Emory community, Brian Michael Olson, PhD.
Supported by a $6 million grant from the Robert W. Woodruff Foundation, The American Cancer Society and Winship are partnering to accelerate cancer research in Georgia by building a cloud-based technical infrastructure to connect researchers and relevant biospecimens and data.
Winship Cancer Institute of Emory University recently opened newly renovated spaces at its Clifton campus and Emory Johns Creek Hospital that enhance patient service offerings and improve overall flow for patients and staff.
Kimberly A. Curseen, MD, has been named director of the Palliative Medicine Program at Winship Cancer Institute of Emory University, effective Feb. 1.
The 2023 Georgia Cancer Summit brought together public health professionals, providers, advocates, researchers and community-based organizations to catalyze efforts to advance cancer health equity and reduce the burden of cancer in the state.
A new pre-clinical study by Winship researchers suggests promising new strategies to improve the efficacy of immunotherapy in patients with triple negative breast cancer.
Winship researchers and colleagues from several health care systems and universities have discovered a new AI-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy.
Winship study uncovers certain vaccine-related concerns that should be addressed by health care providers.
A large first-of-its-kind study finds that expanded Medicaid coverage under the Affordable Care Act leads to better survival outcomes for young adults newly diagnosed with cancer.
Winship has appointed Renee Read, PhD, as assistant director for basic research, and Carlos Moreno, PhD, as assistant director for education and training.
A new preclinical study recently reported in Science Advances and led by Emory and UTSW researchers suggests that cooling brain tumors to room temperature may extend survival of patients with glioblastoma multiforme.
Winship physicians, researchers and trainees will lead sessions and present cutting-edge research at the 64th American Society of Hematology (ASH) Meeting and Exposition in New Orleans, Dec. 10-13, 2022.
A multi-institutional collaboration between Winship and others harnesses the power of artificial intelligence to measure patient risk and determine the benefit of therapy for patients in Indian populations.
Winship breast oncologist Kevin Kalinsky, MD, MS, shared RxPONDER trial results at the 2022 San Antonio Breast Cancer Symposium showing Black women with HR+/HER2- breast cancer have worse outcomes than other racial and ethnic groups.
Researchers from Winship Cancer Institute of Emory University will present abstracts and discuss their latest practice-changing work at the 45th San Antonio Breast Cancer Symposium in San Antonio, Dec. 6-10, 2022.
Early- and mid-career oncologists from Latin America participated in the Winship Preceptorship for Breast/Lung Oncologists aimed at increasing their knowledge and skills to improve their clinical practice back home.
Due to Hurricane Ian's projected path, the 2022 Winship 5K shifted to a virtual-only, but that didn't stop more than 3000 participants from walking and running in their own neighborhoods and raising $1,000,378 so far.
The 2022 Winship Gala raised more than $1.9 million for cancer research at Winship, making it the most successful fundraising event in Emory University’s history.
A multi-institutional collaboration between Winship and others harnesses the power of artificial intelligence to measure patient risk and determine the benefit of therapy for patients in Indian populations.
A $1.34 million NIH grant-funded Winship program will study whether using community case studies to engage Georgia middle schoolers in STEM studies will reduce health and biomedical research workforce disparities.
Emory Healthcare is the first in the Southeast to employ a novel comprehensive robotic system for interventional radiology procedures that guides physicians to identify cancerous growths more quickly and accurately.
The Society for Immunotherapy of Cancer's annual meeting, taking place Nov. 8-12, will feature research from Winship investigators that could change how cancer is prevented, diagnosed and treated using immune-based approaches.
Over 200 trainees, researchers, faculty and staff attended the Winship Scientific Symposium on Friday, Nov. 4, an annual event highlighting innovative science at Winship Cancer Institute of Emory University.
Winship member Sharon Castellino, MD, MSc, and colleagues from Children’s Healthcare of Atlanta and Roswell Park led a pediatric multicenter study showing targeted therapy for high-risk Hodgkin lymphoma reduces relapse.
Winship joins call to action urging individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer.
Winship radiation oncologists and researchers led 31 presentations, posters and moderated sessions at the ASTRO annual meeting in San Antonio, Oct. 23-26, 2022.
Winship medical oncologist Kevin Kalinsky, MD, MS, led an arm of a national clinical trial that found that patients with various cancer types harboring the rare AKT1 E17K mutation benefited from treatment with the AKT inhibitor ipatasertib.
The Prostate Cancer Foundation named Winship Cancer Institute of Emory University radiation oncologist Sagar Patel, MD, a recipient of the Class of 2022 Young Investigator Awards.
Winship-led study finds that the combination of an immunotherapy, PD-1 blockade, and biologic therapy, IL-2 therapy, changes CD8+ T cells into more effective partners against cancer and chronic viral infections.
Winship and Georgia Institute of Technology researchers have developed a device that reliably and efficiently detects cell clusters that spread cancer, enabling minimally invasive prognosis and diagnosis and improving the clinical management of cancer.
Winship and Georgia Tech researchers receive NCI award to study how interactions between patient-level factors, tumor genetics and the tumor microenvironment contribute to racial disparities in diagnosis, survival and treatment.
Winship led study suggests the likelihood of patients with myeloma achieving durable responses to CART therapy may depend on properties of their immune cells before CARTs are administered.
The NCI recently awarded more than $7.9 million to support a new Radiation Oncology-Biology Integration Network (ROBIN) center at Winship Cancer Institute of Emory University and the Cleveland Clinic.
Winship welcomes the newest cancer researchers and clinicians to join the Emory University School of Medicine faculty and celebrates faculty promotions.
On Oct. 1, Emory Healthcare will migrate from Cerner's electronic medical record to Epic's integrated and comprehensive health care software. Patients can expect to see an advanced patient experience.
Whether you run, walk or stroll, compete in person or log your miles virtually, you can support research advances against cancer by taking part in the Winship 5K on Oct. 1.
Winship investigators are leading study to understand role of oral health in persistent HPV and oropharyngeal cancer in people living with HIV.
Internationally recognized breast cancer and bioethics researcher and radiation oncologist, Reshma Jagsi, MD, DPhil, will join Emory School of Medicine and Winship as chair of the Department of Radiation Oncology, effective Nov. 7, 2022.
Four Winship trainees are recipients of this year's Nell W. and William Simpson Elkin Fellowship and Chester Rochfort Scholarship.
A study recognized as a "Best Paper of 2021" shows multidisciplinary therapy improves overall survival for women with metastatic inflammatory breast cancer.
Winship and Children’s Healthcare of Atlanta researchers find that the combination therapy of osimertinib and a second drug the group developed is effective in reversing resistance when treating non-small cell lung cancer.
A Winship-led study offers new insight into what causes resistance to the non-small cell lung cancer medication osimertinib that may prove valuable in developing more effective therapies.
Winship opens phase 3 cell therapy study combining purified matched donor cells and showing promise in preventing GvHD and disease relapse in certain blood cancers.
The International Cardio-Oncology Society (ICOS) has designated Winship a gold-level Cardio-Oncology "Center of Excellence," one of fewer than 35 gold-level centers worldwide.
The New England Journal of Medicine reports Winship-led study of combination therapy potentially benefiting people with relapsed multiple myeloma.
The UGA-Winship Cancer Research Summit explored the strengths and synergies of Winship's collaboration with UGA aimed at accelerating cancer prevention, diagnosis and treatment and educating the next generation of cancer researchers.
Winship Cancer Institute of Emory University is ranked in the top 50 in the United States and number one in Georgia and metro Atlanta for cancer care, according to U.S. News and World Report.
Emory has been named Georgia’s first and only Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine and Molecular Imaging.
Winship Cancer Institute of Emory University, Emory University School of Medicine and Grady Memorial Hospital mourn the loss of Jerome Carl Landry, MD, MBA, professor of radiation oncology.
Research by Yang Lei, PhD, and other Winship investigators will be featured at the 2022 meeting of the American Association of Physicists in Medicine in Washington, D.C.
Winship physicians are among the over 400 Emory Healthcare doctors recognized in Atlanta magazine’s annual roster of the city's best doctors.
Winship investigator Lisa Flowers, MD, and her colleagues find that routinely screening and treating precancerous anal lesions greatly decreases the likelihood of progression to anal cancer.
Kenneth Cardona, MD, professor of surgery and the Sarcoma Disease Team lead for Winship, has been named the inaugural holder of the Patricia R. Reynolds Endowment for Sarcoma Research at Winship.
A new study conducted by Winship researchers finds that COVID-19 vaccines are much less effective for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Stacy L. Palmer, MBA, will join Winship Cancer Institute of Emory University on June 6 as the new vice president of clinical administration and strategy.
Ninety-one percent of treatment-limited participants with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) experienced clinical benefit in a phase 2 clinical trial led by Winship investigators.
Winship investigators have been awarded a P01 program project grant from the National Cancer Institute (NCI) to support research aimed at improving the effectiveness of immunotherapy for lung cancer in patients.
Winship members will present research, chair and moderate sessions and receive awards at the 2022 American Society of Clinical Oncology Annual Meeting taking place virtually and in Chicago June 3-7, 2022.
Emory nurses, including 12 who support Winship Cancer Institute patients, have been selected as the winners of this year's Emory Healthcare Nursing Excellence Awards.
Lauren McCullough, PhD, MSPH, and her team are hosting a virtual forum to share information and gather community input on the possible causes of breast cancer inequities across Georgia.
The 2022 Friends of Winship Fashion a Cure Fashion Show on May 3 raised more than $280,000 to support research conducted at Winship Cancer Institute of Emory University in cancers that affect women.
Winship researchers and colleagues have revealed widespread distortions of a cell's protein interaction machinery resulting from cancer-causing mutations, developing anticancer drug opportunities.
New research from Winship and collaborators sheds new light on how patients with cancer develop depression. The study was recently published in the journal Cancer.
Winship and Emory Vaccine Center researchers have obtained a detailed picture of the immune cells present within brain metastases, with an eye toward re-activating and enhancing those cells with cancer immunotherapy.
Winship Cancer Institute of Emory University will open the first immediate cancer care center in Georgia providing acute care for Winship patients experiencing cancer-related symptoms that require immediate medical care.
Eleven investigators will receive a total of $700,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship.
The 113th annual American Association for Cancer Research (AACR) meeting in New Orleans features numerous oral and poster presentations by Winship and Emory University investigators and trainees.
Four Winship investigators have been awarded pilot grants from the Donaldson Charitable Trust Research Synergy Fund, funded in part by contributions from the Oliver S. and Jennie R. Donaldson Charitable Trust.
Winship researchers are testing for the first time in patients an investigational drug that is intended to improve outcomes for patients with relapsed myeloma missing a particular chromosome.
Renowned gynecologic oncologist and researcher, Susan C. Modesitt, MD, will lead the gynecologic oncology program at Winship Cancer Institute of Emory University.
The 2022 Multidisciplinary Head and Neck Cancers Symposium held Feb. 24-26 in Phoenix featured oral and poster presentations from several Winship experts.
Kevin Kalinsky, MD, MS, director of Winship Cancer Institute of Emory University's Glenn Family Breast Center, has been named to the Louisa and Rand Glenn Family Chair in Breast Cancer Research.
Winship Cancer Institute of Emory University has opened a new shared resource hub on the third floor of Emory Building B on Clifton Road.
Winship has received a $1.5 million gift from longtime volunteer and philanthropist Brenda Nease to establish the David H. Lawson Professorship in Cancer Research in honor of one of Winship's most eminent physicians.
Winship neurosurgeon-scientist Edjah Nduom, MD, was tapped to introduce President Biden at a White House ceremony to relaunch the Cancer Moonshot initiative on February 3.
The John H. Kauffman Prostate Cancer Fundraiser, hosted annually by the Dunwoody Country Club's Champions Golf Association, raised $400,000 in support of prostate cancer research at their 2021 event on Oct. 12.
A new collaboration by Emory Healthcare, Winship Cancer Institute and AccessHope will increase access to specialized cancer expertise for people living with complex cancers.